deltatrials

Fondazione IRCCS Policlinico San Matteo di Pavia Clinical Trials

Sponsors / Fondazione IRCCS Policlinico San Matteo di Pavia

Fondazione IRCCS Policlinico San Matteo di Pavia is listed as the lead sponsor on 227 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 86 are in recruitment, 15 are active non-recruiting, and 77 have reached completion. 8 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Across the portfolio, planned enrollment totals 150,461 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

227
Total Trials
86
Recruiting
15
Other Active
77
Completed
8
Terminated / Withdrawn
150,461
Total Enrollment

Termination reasons: Recruitment50% · Other38% · Efficacy13%

Recent Terminations

  • NCT04895917 Phase PHASE2 Stopped Jan 2025
    AL Amyloidosis
    "low patient enrollment rate"
  • NCT03949907 Phase NA Stopped Jul 2024
    Cancer of Stomach
    "Changes in anticancer treatment protocols which limit recruitment"
  • NCT03474458 Phase PHASE2/PHASE3 Stopped May 2022
    Cardiac AL Amyloidosis
    "difficulty in recruitment"
  • NCT04756856 Phase NA Stopped May 2022
    Sarcopenia
    "Significant change in the profile of recruitable patients"
  • NCT00911339 Phase PHASE3 Stopped May 2021
    Stable Coronary Artery Disease
    "prematurely interrupted because of difficulty in enrolment of patients."
  • NCT04422743 Phase NA Stopped Sep 2020
    Glaucoma
    "due to covid 19 pandemy"
  • NCT02887950 Phase NA Stopped Sep 2019
    Overweight
    "No benefit at iterim analysis"
  • NCT01511263 Phase PHASE2 Stopped Jul 2016
    Primary Amyloidosis of Light Chain Type

Active Trials (15 total)

Top Conditions

Top Locations